ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesChapter 12: Diseases of the skin and subcutaneous tissueL63

L63

Non-billable

Alopecia areata

Chapter 12:Diseases of the skin and subcutaneous tissue

BILLABLE STATUSNo
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 L63 is a used to indicate a diagnosis of alopecia areata.

Key Diagnostic Point:

Alopecia areata (L63) is an autoimmune condition characterized by the sudden loss of hair in one or more circular patches on the scalp or other areas of the body. This condition can affect individuals of any age, gender, or ethnicity, and its exact cause remains unclear, although it is believed to involve genetic and environmental factors. Alopecia areata can present in various forms, including alopecia totalis (complete scalp hair loss) and alopecia universalis (total body hair loss). The clinical significance of this condition lies not only in its physical manifestations but also in its psychological impact on affected individuals, leading to anxiety, depression, and social withdrawal.

  • In terms of usage guidelines, L63 codes should be employed when documenting cases of alopecia areata, with specific attention to the type and extent of hair loss. Accurate coding is essential for effective treatment planning and management, as well as for tracking the condition's prevalence and outcomes in different populations. Clinicians should ensure that the diagnosis is supported by thorough clinical evaluation and, when necessary, additional diagnostic tests to rule out other causes of hair loss.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Variability in presentation
  • Potential for misdiagnosis
  • Need for differential diagnosis

Audit Risk Factors

  • Inadequate documentation
  • Misuse of related codes
  • Failure to specify type of alopecia

Specialty Focus

Medical Specialties

Dermatology

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Primary Care

Documentation Requirements

Standard ICD-10-CM documentation requirements apply

Common Clinical Scenarios

Various clinical presentations within this specialty area

Billing Considerations

Follow specialty-specific billing guidelines

Related CPT Codes

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

CPT Code

Clinical Scenario

Documentation Requirements

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The clinical impact of the L63 code category extends beyond individual patient care, influencing quality measures and population health initiatives. Accurate coding of alopecia areata is essential for understanding the epidemiology of the condition and for developing targeted interventions that address the psychological and social implications of hair loss. As healthcare trends evolve towards a more holistic approach to patient care, the importance of recognizing and treating alopecia areata as a significant health issue is increasingly acknowledged.
Administratively, the use of L63 codes can affect healthcare resource allocation and funding for research into effective treatments. As awareness of alopecia areata grows, there is a push for improved patient education and support services, which can ultimately lead to better health outcomes and enhanced quality of life for those affected by this condition.

ICD-9 vs ICD-10

The clinical impact of the L63 code category extends beyond individual patient care, influencing quality measures and population health initiatives. Accurate coding of alopecia areata is essential for understanding the epidemiology of the condition and for developing targeted interventions that address the psychological and social implications of hair loss. As healthcare trends evolve towards a more holistic approach to patient care, the importance of recognizing and treating alopecia areata as a significant health issue is increasingly acknowledged. Administratively, the use of L63 codes can affect healthcare resource allocation and funding for research into effective treatments. As awareness of alopecia areata grows, there is a push for improved patient education and support services, which can ultimately lead to better health outcomes and enhanced quality of life for those affected by this condition.

Reimbursement & Billing Impact

Reimbursement may vary based on the complexity of the case and the specific interventions provided. It is crucial to ensure that all services are well-documented and that the coding accurately reflects the patient's condition and the treatment provided. Additionally, insurance policies may have specific requirements for prior authorization or coverage limitations for certain treatments, such as corticosteroid injections or topical therapies.

Resources

Clinical References

  • •
    Official ICD-10 Guidelines for L63

Coding & Billing References

  • •
    Official ICD-10 Guidelines for L63

Frequently Asked Questions

What conditions are included in L63?

L63 includes alopecia areata, alopecia totalis, and alopecia universalis, as well as other forms of patchy hair loss that are autoimmune in nature.

When should I use L63 codes?

L63 codes should be used when a patient presents with symptoms of hair loss consistent with alopecia areata, and the diagnosis has been confirmed through clinical evaluation.

What documentation is required for L63?

Documentation should include a detailed history of the patient's hair loss, physical examination findings, and any relevant laboratory tests or referrals to specialists.